Cencora Inc.
Cencora, Inc. sources and distributes pharmaceutical products in the United States and internationally. The company's U.S. Healthcare Solutions segment distributes generic and injectable pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order … Read more
Cencora Inc. (COR) - Total Assets
Latest total assets as of December 2025: $78.36 Billion USD
Based on the latest financial reports, Cencora Inc. (COR) holds total assets worth $78.36 Billion USD as of December 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Cencora Inc. - Total Assets Trend (1994–2025)
This chart illustrates how Cencora Inc.’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Cencora Inc. - Asset Composition Analysis
Current Asset Composition (September 2025)
Cencora Inc.'s total assets of $78.36 Billion consist of 68.2% current assets and 31.8% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $4.36 Billion | 5.7% |
| Accounts Receivable | $25.23 Billion | 32.9% |
| Inventory | $20.49 Billion | 26.8% |
| Property, Plant & Equipment | $4.09 Billion | 5.3% |
| Intangible Assets | $3.77 Billion | 4.9% |
| Goodwill | $13.68 Billion | 17.9% |
Asset Composition Trend (1994–2025)
This chart illustrates how Cencora Inc.'s asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Cencora Inc.'s current assets represent 68.2% of total assets in 2025, a decrease from 91.6% in 1994.
- Cash Position: Cash and equivalents constituted 5.7% of total assets in 2025, up from 3.6% in 1994.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 21.0% of total assets, an increase from 0.0% in 1994.
- Asset Diversification: The largest asset category is accounts receivable at 32.9% of total assets.
Cencora Inc. Competitors by Total Assets
Key competitors of Cencora Inc. based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
C.Q. Pharmaceutical Holding Co Ltd
SHE:000950
|
China | CN¥67.71 Billion |
|
Shenzhen Glory Medical Co Ltd
SHE:002551
|
China | CN¥3.56 Billion |
|
Shandong Realcan Pharmaceutical Co Ltd
SHE:002589
|
China | CN¥15.33 Billion |
|
Hanmi Science
KO:008930
|
Korea | ₩1.45 Trillion |
|
BCM Alliance Bhd
KLSE:0187
|
Malaysia | RM147.86 Million |
|
Qingdao Baheal Medical INC.
SHE:301015
|
China | CN¥7.59 Billion |
|
Excelsior Medical Co Ltd
TW:4104
|
Taiwan | NT$18.80 Billion |
|
CHC Healthcare Group
TW:4164
|
Taiwan | NT$14.83 Billion |
Cencora Inc. - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Strong asset utilization - Cencora Inc. generates 4.20x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Moderate ROA - For every $100 in assets, Cencora Inc. generates $ 2.03 in net profit.
Cencora Inc. - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.92 | 0.92 | 1.07 |
| Quick Ratio | 0.51 | 0.54 | 0.68 |
| Cash Ratio | 0.03 | 0.06 | 0.00 |
| Working Capital | $-4.98 Billion | $ -4.52 Billion | $ 2.47 Billion |
Cencora Inc. - Advanced Valuation Insights
This section examines the relationship between Cencora Inc.'s asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 35.79 |
| Latest Market Cap to Assets Ratio | 0.81 |
| Asset Growth Rate (YoY) | 14.1% |
| Total Assets | $76.59 Billion |
| Market Capitalization | $62.31 Billion USD |
Valuation Analysis
Near Book Valuation: The market values Cencora Inc.'s assets close to their book value ( 0.81x), suggesting investors view the company's assets at approximately fair value.
Rapid Asset Growth: Cencora Inc.'s assets grew by 14.1% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Cencora Inc. (1994–2025)
The table below shows the annual total assets of Cencora Inc. from 1994 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-09-30 | $76.59 Billion | +14.14% |
| 2024-09-30 | $67.10 Billion | +7.26% |
| 2023-09-30 | $62.56 Billion | +10.60% |
| 2022-09-30 | $56.56 Billion | -1.36% |
| 2021-09-30 | $57.34 Billion | +29.50% |
| 2020-09-30 | $44.27 Billion | +13.03% |
| 2019-09-30 | $39.17 Billion | +3.99% |
| 2018-09-30 | $37.67 Billion | +6.66% |
| 2017-09-30 | $35.32 Billion | +5.14% |
| 2016-09-30 | $33.59 Billion | +21.10% |
| 2015-09-30 | $27.74 Billion | +28.81% |
| 2014-09-30 | $21.53 Billion | +13.81% |
| 2013-09-30 | $18.92 Billion | +22.50% |
| 2012-09-30 | $15.44 Billion | +3.08% |
| 2011-09-30 | $14.98 Billion | +3.80% |
| 2010-09-30 | $14.43 Billion | +6.35% |
| 2009-09-30 | $13.57 Billion | +11.09% |
| 2008-09-30 | $12.22 Billion | -0.75% |
| 2007-09-30 | $12.31 Billion | -3.71% |
| 2006-09-30 | $12.78 Billion | +12.33% |
| 2005-09-30 | $11.38 Billion | -2.34% |
| 2004-09-30 | $11.65 Billion | -3.21% |
| 2003-09-30 | $12.04 Billion | +7.38% |
| 2002-09-30 | $11.21 Billion | +8.96% |
| 2001-09-30 | $10.29 Billion | +318.59% |
| 2000-09-30 | $2.46 Billion | +19.31% |
| 1999-09-30 | $2.06 Billion | +32.74% |
| 1998-09-30 | $1.55 Billion | -11.04% |
| 1997-09-30 | $1.75 Billion | +46.89% |
| 1996-09-30 | $1.19 Billion | +41.65% |
| 1995-09-30 | $838.70 Million | +17.86% |
| 1994-09-30 | $711.60 Million | -- |